Iktos

French tech company | Builders Republic

About

Maker of generative-AI software for small-molecule drug discovery — its Makya platform designs novel compounds and Spaya plans synthesis routes, increasingly coupled with automated lab robotics to run design-make-test-analyse cycles for pharma and biotech partners.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Series A
Founded
2016
City
PARIS
Region
IDF
Tracked rounds
1
Amount raised
16 M€ raised since 2020

Funding rounds

  • Series A — 2023

Investors